Your session is about to expire
← Back to Search
Stent-Graft
Acute Technical Outcomes of the Talent Abdominal Aortic Aneurysm (AAA) Stent-Graft Versus Cook Zenith Stent-Graft
N/A
Waitlist Available
Led By Manish Mehta, MD, MPH
Research Sponsored by Center for Vascular Awareness, Albany, New York
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
The purpose of this study is to compare acute technical outcomes of the Talent AAA Stent Graft system versus Cook Zenith Endograft at two high volume institutions, Albany Medical Center and St. Peter's Hospital in Albany, NY. The investigators are comparing the two devices as part of the evolution of endovascular repair (EVAR) for AAAs. The Zenith AAA Endovascular Graft received FDA approval on May 23, 2003, the Talent Abdominal Stent Graft System on April 15, 2008.
Eligible Conditions
- Abdominal Aortic Aneurysm
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Talent Stent-GraftExperimental Treatment2 Interventions
Group II: Cook Zenith Stent-GraftExperimental Treatment2 Interventions
Find a Location
Who is running the clinical trial?
Center for Vascular Awareness, Albany, New YorkLead Sponsor
1 Previous Clinical Trials
2 Total Patients Enrolled
Manish Mehta, MD, MPHPrincipal InvestigatorThe Vascular Group, PLLC
3 Previous Clinical Trials
306 Total Patients Enrolled